• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调整预后因素不平衡的设计后的推断。

Inference following designs which adjust for imbalances in prognostic factors.

机构信息

Medicines and Healthcare Products Regulatory Agency, London, UK.

出版信息

Clin Trials. 2013 Aug;10(4):540-51. doi: 10.1177/1740774513493367. Epub 2013 Jul 5.

DOI:10.1177/1740774513493367
PMID:23832671
Abstract

BACKGROUND

When the minimisation method due to Taves is used to balance treatment groups across prognostic factors, a problem arises at the time of analysing the results. Since minimisation is essentially a deterministic method, any statistical test based on the assumption of complete randomisation should not be used in the analysis. Previous articles have shown that analysis of covariance (ANOCOVA) produces valid tests.

METHODS

In this article, these results are extended to trials with more than one prognostic factor and more than two treatments. An alternative design to minimisation which makes use of optimum design theory is also considered, with two choices of biased coin. Simulation is used to study the effect on the power and the coverage probabilities of the usual tests and confidence intervals when these different allocation methods are applied. The results are then illustrated using data from an actual clinical trial.

RESULTS

Simulation shows that when ANOCOVA is used, it is sometimes more powerful with these designs than with minimisation and produces slightly conservative confidence intervals for the treatment mean differences. The increase in power and conservativeness is more pronounced when there are more prognostic factors. The possibility of treatment-covariate interactions is also addressed.

LIMITATIONS

Results are only given when treatment responses are normally distributed.

CONCLUSIONS

Under the simulated situations considered, when a covariate-adaptive design is used, the use of ANOCOVA yields a test which preserves the nominal significance level as compared to the conservativeness of analysis of variance.

摘要

背景

当采用 Taves 的最小化方法来平衡预后因素的治疗组时,在分析结果时会出现问题。由于最小化本质上是一种确定性方法,因此不应在分析中使用基于完全随机化假设的任何统计检验。以前的文章表明,协方差分析 (ANCOVA) 可产生有效的检验。

方法

本文将这些结果扩展到具有多个预后因素和两个以上治疗的试验中。还考虑了一种替代最小化的设计,该设计利用最佳设计理论,并采用两种有偏硬币选择。通过模拟研究了当应用这些不同的分配方法时,对常用检验的功效和覆盖概率的影响以及置信区间。然后使用实际临床试验的数据来说明结果。

结果

模拟表明,当使用 ANCOVA 时,它在这些设计中有时比最小化更有效,并为治疗均值差异产生略微保守的置信区间。当存在更多的预后因素时,功效和保守性的增加更为明显。还讨论了治疗协变量交互作用的可能性。

局限性

仅在治疗反应正态分布时给出结果。

结论

在考虑的模拟情况下,当使用协变量自适应设计时,与方差分析的保守性相比,使用 ANCOVA 可产生保留名义显着性水平的检验。

相似文献

1
Inference following designs which adjust for imbalances in prognostic factors.调整预后因素不平衡的设计后的推断。
Clin Trials. 2013 Aug;10(4):540-51. doi: 10.1177/1740774513493367. Epub 2013 Jul 5.
2
Bias and loss: the two sides of a biased coin.偏倚与损失:一枚硬币的两面。
Stat Med. 2012 Dec 10;31(28):3494-503. doi: 10.1002/sim.5416. Epub 2012 Jun 27.
3
On efficient two-stage adaptive designs for clinical trials with sample size adjustment.关于具有样本量调整的临床试验的高效两阶段自适应设计。
J Biopharm Stat. 2012;22(4):617-40. doi: 10.1080/10543406.2012.678226.
4
Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation method.最小化法在非比例风险随机对照试验中渐近检验和再随机检验的比较。
BMC Med Res Methodol. 2024 Jul 30;24(1):166. doi: 10.1186/s12874-024-02295-2.
5
Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.用于在具有正态反应的临床试验中使分配比例倾斜的自适应偏倚硬币设计。
Stat Med. 2005 Aug 30;24(16):2477-92. doi: 10.1002/sim.2124.
6
Validity of tests under covariate-adaptive biased coin randomization and generalized linear models.协变量自适应偏倚硬币随机化和广义线性模型下检验的有效性
Biometrics. 2013 Dec;69(4):960-9. doi: 10.1111/biom.12062. Epub 2013 Jul 12.
7
Adaptive group sequential test with changing patient population.针对不断变化的患者群体的适应性成组序贯试验。
J Biopharm Stat. 2012;22(4):662-78. doi: 10.1080/10543406.2012.678808.
8
Optimization of adaptive designs: efficiency evaluation.适应性设计的优化:效率评估
J Biopharm Stat. 2012;22(4):641-61. doi: 10.1080/10543406.2012.676532.
9
On design considerations and randomization-based inference for community intervention trials.关于社区干预试验的设计考量及基于随机化的推断
Stat Med. 1996 Jun 15;15(11):1069-92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q.
10
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.序贯样本量重新估计试验后参数估计及其精确置信区间
Biometrics. 2004 Dec;60(4):910-8. doi: 10.1111/j.0006-341X.2004.00246.x.

引用本文的文献

1
A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment.一项针对创伤后应激障碍(PTSD)的一流血管加压素1a受体拮抗剂的概念验证随机交叉临床试验:设计、方法和招募情况。
Contemp Clin Trials Commun. 2023 Mar 17;33:101116. doi: 10.1016/j.conctc.2023.101116. eCollection 2023 Jun.